glp-1 lilly Earnings from Eli Lilly, Novo Nordisk, and Hims & Hers Health FDA approves Foundayo, an oral

These treatments, when administered properly, can lead to sustainable weight loss by helping individuals make healthier dietary choices, reducing cravings, and enhancing satiety after meals

So when we eat enough fiber, we probably arent starving in between meals or feeling hangry as we get closer to the next meal

New products and launches Texas-based Ozzi has launched Crave Crusher, a plant-based drink designed to suppress appetite and serve as an alternative to GLP-1 drugs

Semaglutide can help people lose an average of 18% of their body weight at the highest dose (Wegovy 7.2 mg), and tirzepatide has been associated with an average of 21% at the 15 mg dose of Zepbound

While not always a complete disqualifier, patients who have a history of the following conditions should likely avoid Semaglutide: Multiple endocrine neoplasia syndrome type 2 (MEN2) Pancreatitis Gallbladder problems Thyroid cancer Type I diabetes History of severe symptoms of low blood sugar If a patient currently takes a GLP-1 medication, they may be able to switch to Semaglutide

"In the longer term, however, reduced obesity rates among Medicaid enrollees could also result in reduced Medicaid spending on chronic diseases associated with obesity, such as heart disease, Type 2 diabetes and types of cancer," the researchers noted in a KFF news release